Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06720142 · ClinicalTrials.gov registry record
Mg OSTEOCRETE Post-Treatment Outcomes
A clinical trial of Trauma and Cancer of Bone, sponsored by Santiago Lozano-Calderon.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06720142: Recruiting study of Trauma and Cancer of Bone, sponsored by Santiago Lozano-Calderon.
NCT06720142 is a study of Trauma and Cancer of Bone that is actively recruiting participants, run by Santiago Lozano-Calderon. The registered enrollment target is 10 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06720142, a study of Trauma and Cancer of Bone, is actively recruiting participants, sponsored by Santiago Lozano-Calderon.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.
Primary Outcome
To determine the time to complete bone remodeling after injection of a magnesium-based bone graft substitute (Mg OSTEOCRETE™), as determined by Hounsfield Units on computed tomography (CT) scan.
Conditions Studied
Interventions
- DEVICE Mg OSTEOCRETE as a bone void filler
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2026-06 |
What NCT06720142 shows while recruiting
NCT06720142 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Mg OSTEOCRETE as a bone void filler is the first listed.
NCT06720142 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06720142 about?
NCT06720142 is a clinical study titled "Mg OSTEOCRETE Post-Treatment Outcomes". Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to ...
What is the current status of trial NCT06720142?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-03-17. Estimated completion is 2026-06.
What conditions does trial NCT06720142 study?
This clinical trial studies the following conditions: Trauma, Cancer of Bone, Aseptic Loosening of Orthopaedic Hardware.
What interventions are being tested in trial NCT06720142?
The interventions under investigation include: Mg OSTEOCRETE as a bone void filler (DEVICE).
Who is sponsoring clinical trial NCT06720142?
This trial is sponsored by Santiago Lozano-Calderon, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06720142 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06720142's enrollment target sits among peer trials
10 56th of 56 higher than 1 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI